2B70:XETRA:XETRA-iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) (EUR)

ETF | Others |

Last Closing

USD 6.1

Change

0.00 (0.00)%

Market Cap

USD 0.52B

Volume

0.05M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-06-15 )

ETFs Containing 2B70:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 5.87% 53% F 55% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 5.87% 52% F 54% F
Trailing 12 Months  
Capital Gain 9.18% 54% F 57% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 9.18% 54% F 56% F
Trailing 5 Years  
Capital Gain 44.89% 64% D 66% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 44.89% 62% D 62% D
Average Annual (5 Year Horizon)  
Capital Gain 5.92% 56% F 55% F
Dividend Return 5.92% 55% F 53% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 14.07% 44% F 55% F
Risk Adjusted Return 42.08% 50% F 54% F
Market Capitalization 0.52B 68% D+ 60% D-

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.